Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 26, 2022, Sigilon Therapeutics, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The following is a brief description of each proposal voted upon at the Annual Meeting and the final voting results for each such proposal.

Proposal 1: Election of Directors

The stockholders of the Company elected the director nominees listed below to serve on the Company's Board of Directors as members of Class II for a term of three years. The results of the vote were as follows:



Name of Nominee                   For      Against   Abstain  Broker Non-Votes

Rogerio Vivaldi Coelho, M.D.  19,520,169  1,249,773      956         4,229,374
John Cox                      19,508,412  1,261,559      927         4,229,374
Kavita Patel, M.D.            19,477,859  1,288,906    4,133         4,229,374

Proposal 2: Ratification of the Company's Independent Registered Public Accounting Firm

The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ended December 31, 2022. The results of the vote were as follows:



   For      Against  Abstain
24,875,086  121,003   4,183

© Edgar Online, source Glimpses